Alli Schaper: Microdosing, Mushrooms, and Policy Reform episode artwork

EPISODE · Apr 10, 2025 · 1H 3M

Alli Schaper: Microdosing, Mushrooms, and Policy Reform

from Divergent States · host Divergent States

In this episode of Divergent States, we sit down with Alli Schaper, CEO of Supermush and co-founder of the Microdosing Collective, to explore the evolving world of functional and psychedelic mushrooms. Alli shares her journey into microdosing advocacy, the challenges of navigating the gray market for psychedelics, and the urgent push for policy reform to ensure safe, legal access.We dive into the science behind microdosing, its profound benefits for mental health, creativity, and even athletic performance, and discuss why current regulations often overlook this powerful tool. Alli opens up about how psychedelics helped her family process grief and why storytelling is key to destigmatizing these substances. The conversation also highlights the risks of unregulated products (like gas station "shrooms"), the importance of community-driven advocacy, and the potential for cultural momentum to shape smarter policies.With psychedelic mushrooms gaining mainstream attention, from wellness brands to underground markets, we ask: Are we "legalizing the whole bottle of wine before the sip"? Tune in for a thought-provoking discussion on the future of microdosing, the role of functional fungi in daily health, and how everyday individuals can help drive this movement forward.Music by DylAlien.TakeawaysMushrooms can have a profound impact on physical and mental health.Microdosing can help maintain mental health and prevent burnout.Psychedelics can be valuable tools for processing grief.There is a cultural gap in understanding and accepting death.Microdosing is often misunderstood and misrepresented in popular culture.Functional mushrooms offer various health benefits beyond nutrition.Community and intentional gatherings are essential for wellness.Advocacy for microdosing is crucial for policy changes.The definition of a microdose is often misinterpreted.The Microdosing Collective aims to represent and support microdosers. There is a need for a legal safe pathway for microdosing.Education and research are crucial for microdosing advocacy.Community involvement enhances the impact of policy reform.The psychedelic gray market poses risks and opportunities.https://www.microdosingcollective.org/https://supermush.comChapters00:00 Introduction to Psychedelic Science 2502:53 Ali Schaper's Journey into Microdosing06:08 Balancing Entrepreneurship and Advocacy09:00 Personal Experiences with Grief and Psychedelics12:01 The Intersection of Wellness and Mortality15:05 Microdosing Collective and Its Goals17:48 Functional Mushrooms vs. Psychedelic Microdosing21:01 Benefits of Functional Mushrooms23:57 Debunking Myths about Microdosing28:45 Legal Pathways for Microdosing30:12 Challenges in Microdosing Policy32:05 Education and Community Engagement34:52 The Role of Everyday Psychonauts36:54 Understanding the Psychedelic Gray Market39:47 Policy Adjustments for Safe Microdosing41:25 Community-Driven Ethos in Regulation43:01 Cultural Momentum and Storytelling45:41 The Renaissance of Psychedelics47:42 Collaborations and Community Initiatives49:01 Supporting the MovementSend us Fan MailFiresideProject.orgDownload the app or text/call 62-FIRESIDEZendo ProjectOur listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showSpecial Thanks to our Macrodosers, Super D and Mike, and our Thumbprint Tier member, Angie on Patreon!  https://linktr.ee/3L1T3Mod

In this episode of Divergent States, we sit down with Alli Schaper, CEO of Supermush and co-founder of the Microdosing Collective, to explore the evolving world of functional and psychedelic mushrooms. Alli shares her journey into microdosing advocacy, the challenges of navigating the gray market for psychedelics, and the urgent push for policy reform to ensure safe, legal access. We dive into the science behind microdosing, its profound benefits for mental health, creativity, and even athlet...

NOW PLAYING

Alli Schaper: Microdosing, Mushrooms, and Policy Reform

0:00 1:03:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Divergent States?

This episode is 1 hour and 3 minutes long.

When was this Divergent States episode published?

This episode was published on April 10, 2025.

What is this episode about?

In this episode of Divergent States, we sit down with Alli Schaper, CEO of Supermush and co-founder of the Microdosing Collective, to explore the evolving world of functional and psychedelic mushrooms. Alli shares her journey into microdosing...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Divergent States episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!